Kos Pharmaceuticals, Inc (KOSP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kos Pharmaceuticals, Inc (KOSP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tom D who wrote (7)	8/11/1997 11:08:00 PM
From: Tom D	of 118

The chemical name is niacin. I found the prospectus on the SEC's web page edgar.sec.gov Niaspan is just fancy niacin. The value of this drug lies in its promised lack of side effects. Kos is downplaying the incidence of side effects. We'll have to scrutinize published data about the true incidence of side effects. Discontinuation rates can be very misleading. People whose entire bodies are one large atherosclerotic plaque will put up with a lot of side effects before quitting a drug which they believe to be their only chance at survival. TDD

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next